FRONTIERS IN BIOSCIENCE;

DATA FORM FOR CANCER STAGING - PLEURAL MESOTHELIOMA





Form # 785-1-032

CLIN PATH DEFINITIONS
    PRIMARY TUMOR (T)

TX Primary tumor cannot be assessed

T0 No evidence of primary tumor

T1 Tumor limited to ipsilateral parietal and/or visceral pleura

T2 Tumor invades any of the following: ipsilateral lung, endothoracic fascia, diaphragm, or pericardium

T3 Tumor invades any of the following: ipsilateral chest wall muscle, ribs, or mediastinal organs or tissues

T4 Tumor directly extends to any of the following: contralateral pleura, lung, peritoneum, intraabdominal organs, or cervical tissues
    LYMPH NODE (N)

NX Regional lymph nodes cannot be assessed

N0 No regional lymph node metastasis

N1 Metastasis in ipsilateral peribronchial and/or ipsilateral hilar lymph nodes, including direct extension

N2 Metastasis in ipsilateral mediastinal and/or subcarinal lymph node(s)

N3 Metastasis in contralateral mediastinal, contralateral hilar, ipsilateral or contralateral scalene, or supreclavicular lymph node(s)
    DISTANT METASTASIS (M)

MX Distant metastasis cannot be assessed

M0 No evidence of distant metastasis

M1 Distant metastasis

Pathologic Stage by: M.D. Date:

CLIN PATH STAGE GROUPING

I T1 N0 M0
      T2 N0 M0

II T1 N1 M0
      T2 N1 M0

III T1 N2 M0
      T2 N2 M0
      T3 N0 M0
      T3 N1 M0
      T3 N2 M0

IV Any T N3 M0
      T4 Any N M0
      Any T Any N M1

Attending: M.D. Date:

 THE FINAL STAGE GROUPING (CLINICAL & PATHOLOGICAL) IS THE RESPONSIBILITY OF THE ATTENDING PHYSICIAN.

Comments:

Patient Name: